Rio de Janeiro
Brazil
Oswaldo Cruz Foundation (FIOCRUZ)
SARS-COV-2, reinfection, Brazil, next generation sequencing, immune response
Dihydroorotate dehydrogenase, fragments, antiviral, host-directed therapy, diarylethines
SARS-CoV-2, COVID-19, trimeric spike protein, equine antibodies, F(ab’)2 fragments, hyperimmune globulins, SARS-CoV-2 Variants, neutralizing antibodies